• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[下丘脑组织细胞增多症X——1例报告]

[Hypothalamic histiocytosis X--report of a case].

作者信息

Ibayashi Y, Sato O, Hotta H, Uede T, Sohma F

出版信息

No Shinkei Geka. 1983 Apr;11(4):395-401.

PMID:6602949
Abstract

Histiocytosis X is a non-neoplastic disorder of unknown etiology characterized by a mass of proliferating histocytes, plasma cells and inflammatory cells forming a granuloma within the reticuloendothelial elements of any organ system in the body. The three clinical syndromes of this condition, eosinophilic granuloma, Hand-Schüller-Christian disease and Letterer-Siwe disease were unified into a single nosological entity by Lichtenstein in 1953. The complication of the central nervous system is shown in the cerebrum, cerebellum, sella turcica, hypothalamus and so on. Hypothalamic histiocytosis X is often found in cases of disseminated histiocytosis X, but an isolated histiocytosis X of the hypothalamus is very rare. Including our case, 16 cases of hypothalamic histiocytosis X were reviewed in this paper. Age at onset was older than disseminated histiocytosis X. The sex ratio was almost equal. Diabetes insipidus was equally found as in other suprasellar masses and it was important as an initial symptom. The CT finding was shown as a homogeneously enhanced mass but no specific finding of CT was seen as suprasellar histiocytosis X. Therefore, differential diagnosis was very difficult. Treatments for this disease were variable. Chemotherapy, irradiation or combination of both were reported. The combination therapy was thought to be the most effective treatment. The relation between this disease and disseminated histiocytosis X is not known. But possibility of transformation of this disease into disseminated histiocytosis X was reported in some papers. Therefore, early diagnosis by biopsy of the hypothalamic lesion was stressed.

摘要

组织细胞增多症X是一种病因不明的非肿瘤性疾病,其特征是大量增殖的组织细胞、浆细胞和炎症细胞在身体任何器官系统的网状内皮组织内形成肉芽肿。1953年,利希滕斯坦将该病症的三种临床综合征,即嗜酸性肉芽肿、汉-许-克病和勒-雪病统一为一个单一的疾病实体。中枢神经系统并发症见于大脑、小脑、蝶鞍、下丘脑等部位。下丘脑组织细胞增多症X常出现在播散性组织细胞增多症X病例中,但孤立性下丘脑组织细胞增多症X非常罕见。包括我们的病例在内,本文回顾了16例下丘脑组织细胞增多症X。发病年龄比播散性组织细胞增多症X大。性别比例几乎相等。尿崩症与其他鞍上肿块一样常见,且作为初始症状很重要。CT表现为均匀强化的肿块,但鞍上组织细胞增多症X未见CT特异性表现。因此,鉴别诊断非常困难。该疾病的治疗方法多样。有报道采用化疗、放疗或两者联合。联合治疗被认为是最有效的治疗方法。该疾病与播散性组织细胞增多症X的关系尚不清楚。但一些论文报道了该疾病转化为播散性组织细胞增多症X的可能性。因此,强调通过下丘脑病变活检进行早期诊断。

相似文献

1
[Hypothalamic histiocytosis X--report of a case].[下丘脑组织细胞增多症X——1例报告]
No Shinkei Geka. 1983 Apr;11(4):395-401.
2
[A case of dural type of histiocytosis X presenting as a mass lesion in the tentorium cerebelli].[1例表现为小脑幕肿块性病变的硬脑膜型组织细胞增多症X]
No Shinkei Geka. 1994 May;22(5):471-6.
3
[Langerhans cell histiocytosis].[朗格汉斯细胞组织细胞增多症]
Orthopade. 1995 Feb;24(1):73-81.
4
[A histiocytosis X without histological findings: a new entity of histiocytosis X].[无组织学表现的组织细胞增多症X:组织细胞增多症X的一种新实体]
Kokyu To Junkan. 1993 Feb;41(2):171-4.
5
[Report of a rare case of Langerhans-cell histiocytosis of the skull base].[一例罕见的颅底朗格汉斯细胞组织细胞增多症报告]
Minerva Med. 1996 Mar;87(3):99-103.
6
Langerhans' cell histiocytosis.朗格汉斯细胞组织细胞增多症
Orthop Clin North Am. 1996 Jul;27(3):615-23.
7
Periodontal manifestations of adult onset of histiocytosis X.
J Periodontol. 1989 Jan;60(1):57-66. doi: 10.1902/jop.1989.60.1.57.
8
Langerhans cell histiocytosis presented as bilateral otitis media and mastoiditis.朗格汉斯细胞组织细胞增多症表现为双侧中耳炎和乳突炎。
Turk J Pediatr. 2008 Jan-Feb;50(1):70-3.
9
[Langerhans cell histiocytosis].[朗格汉斯细胞组织细胞增多症]
Rev Stomatol Chir Maxillofac. 2009 Nov;110(5):287-9. doi: 10.1016/j.stomax.2009.07.008. Epub 2009 Oct 13.
10
[Hypothalamic-infundibular histiocytosis: magnetic resonance findings].[下丘脑-漏斗部组织细胞增多症:磁共振成像表现]
Rev Neurol. 2004;39(2):125-9.